Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05458258 · ClinicalTrials.gov registry record
Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 239
- Enrollment target
NCT05458258: Completed study, sponsored by University of Chicago.
NCT05458258 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05458258 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
This study will explore how malnutrition (poor nutrition/diet) and sarcopenia (a condition that causes a loss of muscle and bone mass) affects study participants over the age of 60 with acute myeloid leukemia (AML) who will receive induction chemotherapy (chemotherapy given as the first treatment to help cancer go into remission) and/or cancer drugs as part of standard care for AML. By studying how these nutritional and skeletal factors, doctors leading this study hope to learn how malnutrition and sarcopenia may be able to predict certain outcomes --such as how long study participants with poor nutrition and muscle loss can live after chemotherapy- for older (age 60+) individuals with AML.
Primary Outcome
This study's primary endpoint aims to measure the association of sarcopenia in study participants with their treatment-related mortality rate (how long the participant can stay alive 60 days after study treatment/registration). The incidence of sarcopenia in study participants will be measured using computed tomography-defined skeletal muscular index , hand grip strength test, and a 6-minute walk test. Treatment related mortality will be defined as the percent of patients no longer alive at 60 d
Interventions
- DEVICE Bioelectrical Impedence Analysis Device
- OTHER 6 Minute Walk Test
- DIAGNOSTIC_TEST Computed Tomography Scans to Measure Skeletal Muscular Index
- DIAGNOSTIC_TEST Blood Test/Blood Draw
- OTHER Hand Grip Strength Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-04-18 |
What the finished NCT05458258 record still lists
NCT05458258 is an observational study that tracks outcomes without assigning an intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Bioelectrical Impedence Analysis Device is the first listed.
NCT05458258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05458258 about?
NCT05458258 is a clinical study titled "Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia". This study will explore how malnutrition (poor nutrition/diet) and sarcopenia (a condition that causes a loss of muscle and bone mass) affects study participants over the age of 60 with acute myeloid leukemia (AML) who will receive induction chemotherapy (chemotherapy given as the first treatment to...
What is the current status of trial NCT05458258?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2023-03-01. Estimated completion is 2025-04-18.
What interventions are being tested in trial NCT05458258?
The interventions under investigation include: Bioelectrical Impedence Analysis Device (DEVICE), 6 Minute Walk Test (OTHER), Computed Tomography Scans to Measure Skeletal Muscular Index (DIAGNOSTIC_TEST), Blood Test/Blood Draw (DIAGNOSTIC_TEST), Hand Grip Strength Test (OTHER).
Who is sponsoring clinical trial NCT05458258?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI